- Citations, last 5 years
- 13.8k
- Works, last 5 years
- 2 014
- h-index
- 580
- Scientists listed
- 0
- Grants since 2016
- 630
Grants received
2021–2026 · research · R01
Role of the p53 P47S mutation in influencing prevalence and immune response to H. pylori
Daniel Thomas Claiborne · The Wistar Institute · funded by National Institutes of Health
2021–2027 · cooperative agreement · UM1
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
Luis J Montaner · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · R01
Drugging EBNA1 to Treat EBV-Associated Cancers
Troy E Messick · The Wistar Institute · funded by National Institutes of Health
2021–2027 · research · R01
Metabolic and epigenetic reprogramming in cyclin E high ovarian cancer
Katherine Marie Aird · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · R00
Integrated analyses of the epigenome to understand the molecular basis of hematopoietic malignancies
Avi Srivastava · The Wistar Institute · funded by National Institutes of Health
2021–2026 · research · R01
Drugging EBNA1 to Treat EBV-Associated Cancers
Troy E Messick · The Wistar Institute · funded by National Institutes of Health
2021–2027 · research · R01
Regulation of EBV Latency by Purine Metabolism and Signaling
Italo Tempera · The Wistar Institute · funded by National Institutes of Health
2021–2026 · program · P50
SPORE in Skin Cancer
Ravi K Amaravadi · The Wistar Institute · funded by National Institutes of Health
2021–2026 · program · P50
Targeting exosomal PDL1 to improve immunotherapy
Wei Guo · The Wistar Institute · funded by National Institutes of Health
2021–2026 · program · P50
Administrative Core
Meenhard F Herlyn · The Wistar Institute · funded by National Institutes of Health
2021–2026 · program · P50
Biostatistics and Bioinformatics Core
Phyllis A. Gimotty · The Wistar Institute · funded by National Institutes of Health
2021–2026 · program · P50
Developmental Research Program
Meenhard F Herlyn · The Wistar Institute · funded by National Institutes of Health
2021–2026 · program · P50
Career Enhancement Program
Jessie Villanueva · The Wistar Institute · funded by National Institutes of Health
2021–2026 · program · P50
Biospecimen and Pathology Core
Xiaowei Xu · The Wistar Institute · funded by National Institutes of Health
2021–2026 · program · P50
Targeting exosomal PDL1 to improve immunotherapy
Wei Guo · The Wistar Institute · funded by National Institutes of Health
2021–2026 · program · P50
Neoadjuvant immunotherapy approaches to early stage melanoma
Meenhard F Herlyn · The Wistar Institute · funded by National Institutes of Health
2021–2026 · program · P50
Neoadjuvant immunotherapy approaches to early stage melanoma
Meenhard F Herlyn · The Wistar Institute · funded by National Institutes of Health
2021–2026 · program · P50
Career Enhancement Program
Jessie Villanueva · The Wistar Institute · funded by National Institutes of Health
2021–2026 · program · P50
Developmental Research Program
Meenhard F Herlyn · The Wistar Institute · funded by National Institutes of Health
2021–2026 · program · P50
Administrative Core
Meenhard F Herlyn · The Wistar Institute · funded by National Institutes of Health
2021–2026 · program · P50
Biostatistics and Bioinformatics Core
Phyllis A. Gimotty · The Wistar Institute · funded by National Institutes of Health
2021–2026 · program · P50
Targeting autophagy to enhance immune checkpoint inhibition
Ravi K Amaravadi · The Wistar Institute · funded by National Institutes of Health
2021–2026 · program · P50
Targeting autophagy to enhance immune checkpoint inhibition
Ravi K Amaravadi · The Wistar Institute · funded by National Institutes of Health
2021–2026 · program · P50
Biospecimen and Pathology Core
Xiaowei Xu · The Wistar Institute · funded by National Institutes of Health
2020–2022 · research · R01
Role of Intestinal Barrier Integrity in Modulating the Host Glycome During COVID-19
Mohamed Abdel Mohsen · The Wistar Institute · funded by National Institutes of Health
2020–2024 · research · R01
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC
Chengyu Liang · The Wistar Institute · funded by National Institutes of Health
2020–2024 · research · R00
Modeling cancer evolution for prediction with neural networks: methods and applications
Noam Auslander · The Wistar Institute · funded by National Institutes of Health
2020–2025 · grant · OCRP
Metabolic Approaches for ARID1A-Mutated Ovarian Cancer
Qin Liu · The Wistar Institute · funded by Congressionally Directed Medical Research Programs
2020–2022 · career development · K99
Genetics of Tumor Suppression by p53
Thibaut Barnoud · The Wistar Institute · funded by National Institutes of Health
2020–2021 · career development · K99
Genetics of Tumor Suppression by p53
Thibaut Barnoud · The Wistar Institute · funded by National Institutes of Health
2020–2025 · research · R01
Regulation of tumor recurrence by stress activated neutrophils
Rugang Zhang · The Wistar Institute · funded by National Institutes of Health
2020–2024 · research · R01
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression
Mohamed Abdel Mohsen · The Wistar Institute · funded by National Institutes of Health
2020–2024 · research · R01
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC
Chengyu Liang · The Wistar Institute · funded by National Institutes of Health
2020–2024 · research · R00
Modeling cancer evolution for prediction with neural networks: methods and applications
Noam Auslander · The Wistar Institute · funded by National Institutes of Health
2020–2024 · research · R01
Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression
Mohamed Abdel Mohsen · The Wistar Institute · funded by National Institutes of Health
2020 · award
Regulation of tumor development and progression by myeloid cells
Dmitry Gabrilovich · The Wistar Institute · funded by American Cancer Society
2020–2023 · research · R01
Role of an Integrator-EGR axis in the regulation of myeloid enhancers (Admin Supp)
Alessandro Gardini · The Wistar Institute · funded by National Institutes of Health
2020–2024 · research · R01
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC
Chengyu Liang · The Wistar Institute · funded by National Institutes of Health
2020–2025 · research · R01
Regulation of tumor recurrence by stress activated neutrophils
Rugang Zhang · The Wistar Institute · funded by National Institutes of Health
2020–2024 · research · R01
Regulation of neonatal inflammation by myeloid-derived suppressor cells
Yulia Nefedova · The Wistar Institute · funded by National Institutes of Health